Redsense Medical AB (XSAT:REDS) Tariff Resilience Score: 0/10 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:REDS Redsense Medical AB XSAT:REDS
54 GF Score
Price kr4.42
GF Value kr6.87
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Redsense Medical AB Tariff Resilience Score?

Redsense Medical AB has the Tariff Resilience Score of 0, which implies that the company might have .

Redsense Medical AB has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Redsense Medical AB might have .

Redsense Medical AB  (XSAT:REDS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Redsense Medical AB Tariff Resilience Score Related Terms

XSAT:REDS
54GF Score
Redsense Medical AB XSAT:REDS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Redsense Medical AB (XSAT:REDS) Overvalued in 2026?

Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued. The current stock price of kr4.42 is trading 35.7% below its estimated GF Value™ of kr6.87. GuruFocus considers Redsense Medical AB to be Possible Value Trap.

Key valuation signals for XSAT:REDS:

  • Tariff Resilience Score: 0
  • GF Value™: kr6.87 vs. price of kr4.42 (35.7% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the XSAT:REDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redsense Medical AB Business Description

Address Storgatan 36, Halmstad, SWE, 302 43
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
54GF Score

Get the complete analysis for XSAT:REDS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.42
Price
kr6.87
GF Value